biquitin proteasome system (UPS) plays an important role in a variety of cellular functions and homeostasis (1) (2) . In this system, degradation of targeted proteins starts with covalent attachment of ubiquitin to substrate followed by a series of enzymatic cascade reactions including activating (E1), conjugating (E2) and ligating (E3) enzymes. Substrate -specific E3s, along with the specific E2s, ensure selective protein targeting for proteolysis (3) . The 26S proteasome, a large multi- Published 19 Feb 2014 revealed the importance of UPS as a key pathway in the cell cycle such as cell signaling (4), apoptosis (5) (6) and growth factor receptor signaling (7) . Therefore, alteration in this system could result in many diseases especially cancers. In our previous studies, we characterized the two new members of E2 family, UBE2Q1 and UBE2Q2 genes, and reported their differential expression in some human cancers. Our preliminary study has shown that the newly characterized human gene, UBE2Q1, is differentially expressed in head and neck squamous cell carcinoma (data not published), breast tumor (8) and colon cancer (9) . According to NCBI database, this gene is located on chromosome Acute Lymphoblastic Leukemia (12) and colon cancer epithelium (13) . The alteration of this gene was also reported in fibroblastoma, glioma and alveolar epithelial carcinoma (14) . Pediatric acute lymphoblastic leukemia (ALL), a malignancy with changes in bone marrow cells is the most common type of leukemia in children under 15 years. It originates in a single B or T lymphocyte progenitor (15) . In this study we investigated the expression of UBE2Q1 gene in patients with ALL and compared it with the healthy normal subjects.
Materials and Methods

Sample preparation
20 bone marrow aspirates from ALL patients of 3 -14 years-old were collected for this study. Table 1 
Results
Clinicopathological data
Discussion
The goal of this study was to investigate the expression pattern of the newly characterized human gene, UBE2Q1 in ALL patients. UBE2Q1
protein contains a predicted highly conserved domain at its carboxy terminal region, UB-CON, suggesting its important catalytic function (17) .
The amino terminal domain of this gene contains an RWD -domain, which is included in about 100 proteins (17) . This domain is suggested to be involved in protein-protein interactions and substrate recognition (18) . In our previous studies we showed that UBE2Q1 is up regulated at mRNA level in head and neck squamous cell carcinoma (unpublished data), and at both protein and mRNA levels in breast (8) and colon cancers (9) . UBE2Q2, a homologue of this gene, is also up regulated at protein and/ or mRNA levels in different cancers (10) (11) (12) (13) . We also showed the alteration of cell cycle progression in cultured cells by UBE2Q2 (19) . 
